Showing results (91-100 of 156) with videos related to
Sort By:
Pageof 16
Leukemia & Lymphoma|November 19, 2020
Analysis of predictors of response to ruxolitinib in patients with myelofibrosis in the phase 3b expanded-access JUMP studyVikas Gupta, Martin Griesshammer, Bruno Martino, et al.Orphanet Journal of Rare Diseases|September 23, 2020
Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher diseaseMarcio M Andrade-Campos, Laura López de Frutos, Jorge J Cebolla, et al.American Journal of Hematology|March 25, 2015
Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trialsDerralynn A Hughes, Derlis E Gonzalez, Elena A Lukina, et al.European Journal of Cancer (Oxford, England : 1990)|February 5, 2008
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United StatesMilena Sant, Claudia Allemani, Roberta De Angelis, et al.Scientific Reports|March 19, 2023
The effect of SARS-CoV-2 variant on respiratory features and mortalityThomas D Hughes, Ajan Subramanian, Rana Chakraborty, et al.Frontiers in Physiology|February 16, 2017
Inhibition of Intermediate-Conductance Calcium-Activated K Channel (KCa3.1) and Fibroblast Mitogenesis by α-Linolenic Acid and Alterations of Channel Expression in the Lysosomal Storage Disorders, Fabry Disease, and Niemann Pick CAida Oliván-Viguera, Javier Lozano-Gerona, Laura López de Frutos, et al.Journal of Inherited Metabolic Disease|February 22, 2012
The cognitive profile of type 1 Gaucher disease patientsMarieke Biegstraaten, Keith A Wesnes, Cécile Luzy, et al.European Journal of Internal Medicine|August 15, 2016
Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in EuropeNadia Belmatoug, Maja Di Rocco, Cristina Fraga, et al.Leukemia & Lymphoma|December 3, 2005
Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantationMaurizio Bendandi, Mercedes Rodríguez-Calvillo, Susana Inogés, et al.Plos One|January 16, 2016
Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C DiseaseAndré R A Marques, Tanit L Gabriel, Jan Aten, et al.Pageof 16